Science Explorer Back to mapMap
Discussion
Researcher · Muhimbili University of Health and Allied Sciences · Tanzania

Lilian Nkinda

Lilian Nkinda publishes mostly in Infectious Diseases, Epidemiology and Pediatrics, Perinatology and Child Health, on topics such as Antibiotic Use and Resistance, SARS-CoV-2 and COVID-19 Research and Pharmaceutical studies and practices.

ORCID 0000-0002-6252-9749 OpenAlex
World rank
#4,488,700
of 7,710,434 ranked researchers
Rank in Tanzania
#2,380
of 3,522
Works
35
Citations
241
Citations per work
6.9
h-index
8
i10-index 8Top 77% in Infectious Diseases
Lilian Nkinda

What does Lilian Nkinda research?

Lilian Nkinda's work is mostly in Medicine (46%), Immunology and Microbiology (6%), Biochemistry, Genetics and Molecular Biology (5%).

Health Sciences: 16 works · 46.4% of their workMedicine: 16 works · 46.4% of their workInfectious Diseases: 6 works · 17.5% of their workEpidemiology: 5 works · 14.4% of their workPediatrics, Perinatology and Child Health: 3 works · 9.3% of their workEmergency Medicine: 2 works · 5.2% of their workEverything else: 15 works · 42.2% of their workLife Sciences: 4 works · 11.4% of their workImmunology and Microbiology: 2 works · 6.2% of their workApplied Microbiology and Biotechnology: 2 works · 6.2% of their workBiochemistry, Genetics and Molecular Biology: 2 works · 5.2% of their workMolecular Biology: 2 works · 5.2% of their workTHEIR WORKLilian Nkinda35works
Life Sciences11%Health Sciences46%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Medicine1646.4%
  2. Everything else1542.2%
    1. Immunology and Microbiology26.2%
    2. Biochemistry, Genetics and Molecular Biology25.2%
  1. 1Infectious Diseases18% of their works
  2. 2Epidemiology14% of their works
  3. 3Pediatrics, Perinatology and Child Health9% of their works
  4. 4Applied Microbiology and Biotechnology6% of their works
  5. 5Emergency Medicine5% of their works
  6. 6Molecular Biology5% of their works

Research topics

Which keywords describe Lilian Nkinda's research?

The keywords of their largest research topics: Epidemiology, Infectious Diseases, Vaccine, Cardiovascular Disease, Insulin Resistance, Antibiotic Resistance, Antimicrobial Stewardship and Coronavirus.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.

All 21 words, with their numbers
  1. Epidemiology123 topics
  2. Infectious Diseases92 topics
  3. Vaccine92 topics
  4. Cardiovascular Disease82 topics
  5. Insulin Resistance82 topics
  6. Antibiotic Resistance61 topic
  7. Antimicrobial Stewardship61 topic
  8. Coronavirus61 topic
  9. Off-Label Drug Use61 topic
  10. Pediatric Pharmacokinetics61 topic
  11. SARS-CoV-261 topic
  12. Antiretroviral Therapy51 topic
  13. HIV Infection51 topic
  14. COVID-19 Vaccine41 topic
  15. Vaccine Hesitancy41 topic
  16. COVID-1931 topic
  17. Diabetes31 topic
  18. Metabolic Syndrome31 topic
  19. Modeling31 topic
  20. Nipah Virus31 topic
  21. Paramyxovirus31 topic

Where does Lilian Nkinda work?

Lilian Nkinda's main affiliation in the publication record is Muhimbili University of Health and Allied Sciences, Tanzania.

How many publications and citations does Lilian Nkinda have?

OpenAlex counts 35 works and 241 citations for Lilian Nkinda, an h-index of 8, ranking #4,488,700 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Lilian Nkinda. Posts are plain text and can be reported.